Maxwell Biosciences

Austin, TX · Founded 2016 · Privately Held (backing)

Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules. Maxwell Biosciences is based in Austin, TX and was founded in 2016. It was valued at $50.9 million at its seed round in Oct 2023, the last priced event on record. It has raised $35.5 million across 1 recorded round; the latest was a $10.9 million early-stage round in Oct 2021.

PMV mark · valuation
$50.9M
Oct 2026
Priced at
its seed round
Oct 2023
Total raised
$35.5M
Last round
Early Stage VC
Oct 2021
How much has Maxwell Biosciences raised?
$35.5Macross 1 recorded rounds · Oct 2021 – Oct 2021

Most recently, Maxwell Biosciences raised $10.9M in its Early Stage VC (Oct 2021).

Free account
More of Maxwell Biosciences with a free account
  • ·The complete investor list: 30 names
  • ·Watch Maxwell Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Maxwell Biosciences round by round

1 rounds
Oct 2021Early Stage VC$10.9MSEC filing▮
96 investors participated

How much has Maxwell Biosciences raised?

Maxwell Biosciences has raised $35.5 million in total; 1 of its rounds is on record. The largest on record was a $10.9 million early-stage round in Oct 2021.

Maxwell Biosciences has filed 2 Form Ds with the SEC since 2022, most recently in Jul 2023 (null sold).

Maxwell Biosciences investors

30 investors are on record for Maxwell Biosciences, including U.S. Department of Energy, Capital Factory, National Institutes of Health and Keiretsu Forum. The early-stage round in Oct 2021 drew 96 investors.

For fundraisers
Raising for a company like Maxwell Biosciences?

30 investors have backed Maxwell Biosciences.

See all 30 investors →

Frequently asked about Maxwell Biosciences

How much has Maxwell Biosciences raised?
Maxwell Biosciences has raised $35.5M in total across 1 recorded funding rounds.
When was Maxwell Biosciences's last funding round?
Maxwell Biosciences's most recent recorded round was Early Stage VC in Oct 2021, raising $10.9M.